0002095188-25-000002.txt : 20251216 0002095188-25-000002.hdr.sgml : 20251216 20251216162808 ACCESSION NUMBER: 0002095188-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251216 DATE AS OF CHANGE: 20251216 EFFECTIVENESS DATE: 20251216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PCR Investment Fund VI, LP CENTRAL INDEX KEY: 0002095188 ORGANIZATION NAME: EIN: 394777335 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-567035 FILM NUMBER: 251575703 BUSINESS ADDRESS: STREET 1: 5847 SAN FELIPE ST., SUITE 1400 CITY: HOUSTON STATE: TX ZIP: 77057 BUSINESS PHONE: 713-629-0500 MAIL ADDRESS: STREET 1: 5847 SAN FELIPE ST., SUITE 1400 CITY: HOUSTON STATE: TX ZIP: 77057 D 1 primary_doc.xml X0708 D LIVE 0002095188 PCR Investment Fund VI, LP 5847 SAN FELIPE ST., SUITE 1400 HOUSTON TX TEXAS 77057 713-629-0500 TEXAS None None Limited Partnership true 2025 n/a PCR Fund VI GP, LLC 5847 San Felipe St Suite 1400 Houston TX TEXAS 77057 Director Promoter General Partner of Issuer. n/a PCR Investment Company, LLC 5847 San Felipe St Suite 1400 Houston TX TEXAS 77057 Executive Officer Promoter Investment Manager of Issuer. Commercial Decline to Disclose 06b false true true true true false 100000 PCR FINANCE GROUP, LLC 315067 None None 5847 SAN FELIPE ST, SUITE 1400 HOUSTON TX TEXAS 77057 CA CALIFORNIA CT CONNECTICUT GA GEORGIA KS KANSAS LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA PA PENNSYLVANIA SC SOUTH CAROLINA TN TENNESSEE TX TEXAS UT UTAH false 250000000 0 250000000 false 0 6250000 true 0 The placement agent will receive a fee that is equal to up to 2.5% of the amounts sold. 0 Affiliates of the Issuer's Investment Manager are entitled to certain fees and an affiliate of the Issuer's General Partner is entitled to a carried interest, all of which are disclosed in the Issuer's confidential offering materials. false PCR Investment Fund VI, LP /s/ Andrew Pappas Andrew Pappas Manager of General Partner of Issuer 2025-12-16